ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 Q82.2

Billable / Specific

Congenital cutaneous mastocytosis

Q82
Block
3
Synonyms
60
LCDs
10
Payer Policies
0
Linked CPTs

About ICD-10-CM Q82.2

ICD-10-CM code Q82.2 represents Congenital cutaneous mastocytosis. This is a billable/specific code in the Congenital Malformations chapter (block Q82). The 2026 edition of ICD-10-CM Q82.2 became effective on October 1, 2025.

Inclusion Terms / Approximate Synonyms

Clinical terms and conditions classified under Q82.2. Per CMS ICD-10-CM Tabular 2026.

  • Congenital diffuse cutaneous mastocytosis
  • Congenital maculopapular cutaneous mastocytosis
  • Congenital urticaria pigmentosa

Type 1 Excludes

Pure excludes, these codes can never be coded together with Q82.2. The conditions are mutually exclusive (e.g., congenital vs acquired forms).

  • cutaneous mastocytosis NOS (D47.01)
  • diffuse cutaneous mastocytosis (with onset after newborn period) (D47.01)
  • malignant mastocytosis (C96.2-)
  • systemic mastocytosis (D47.02)
  • urticaria pigmentosa (non-congenital) (with onset after newborn period) (D47.01)

Medicare LCD Coverage for Q82.2

Local Coverage Determinations (LCDs) from CMS MACs that list Q82.2 as a covered diagnosis.

60 LCDs

Showing top 10 of 60 total . Click a CPT for full coverage scope.

CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer
Article ID: 60240, Effective: , 680 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer
Article ID: 60309, Effective: , 680 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57891, Effective: 2026-02-05 00:00:00, 91 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57891, Effective: 2026-02-05 00:00:00, 91 covered, 0 non-covered
CPT 81451 →
CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57891, Effective: 2026-02-05 00:00:00, 91 covered, 0 non-covered
CPT 81450 →
CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57891, Effective: 2026-02-05 00:00:00, 91 covered, 0 non-covered
CPT 81170 →
CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57878, Effective: 2026-01-22 00:00:00, 90 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57878, Effective: 2026-01-22 00:00:00, 90 covered, 0 non-covered
CPT 81451 →
CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57878, Effective: 2026-01-22 00:00:00, 90 covered, 0 non-covered
CPT 81450 →
CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57878, Effective: 2026-01-22 00:00:00, 90 covered, 0 non-covered
CPT 81170 →

Commercial Payer Coverage

Coverage policies from major commercial payers referencing Q82.2.

10 policies

5 Medicare

Billing and Coding: Removal of Benign Skin Lesions
Policy ID: ART-57044
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Policy ID: ART-57837
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Policy ID: ART-57873
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Policy ID: ART-57878
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Policy ID: ART-57891

1 Aetna

Phototherapy and Photochemotherapy (PUVA) for Skin Conditions
Policy ID: CPB-0205

CPT Codes Commonly Billed with Q82.2

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

No procedure linkages on file for Q82.2

We don't have CPT pairings indexed for this specific code yet. Use the CPT search above to find common procedures, or check your payer's published medical policy for code-specific guidance.

Convert Q82.2 to ICD-9-CM

Per CMS General Equivalence Mappings (GEMs), useful for legacy data review and historical claim analysis.

ICD-10ICD-9Mapping Flags
Q82.2 75733 10000

Flags format (5 digits): Approximate · No Map · Combination · Scenario · Choice List. Source: CMS 2017 GEMs (final version).

ICD-10 Q82.2, Billing FAQ

Is ICD-10 code Q82.2 billable? +

Yes, Q82.2 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

What other names or terms map to Q82.2? +

ICD-10 Q82.2 includes: Congenital diffuse cutaneous mastocytosis; Congenital maculopapular cutaneous mastocytosis; Congenital urticaria pigmentosa.

What codes are Type 1 Excludes for Q82.2? +

Type 1 Excludes (never code together with Q82.2): cutaneous mastocytosis NOS (D47.01); diffuse cutaneous mastocytosis (with onset after newborn period) (D47.01); malignant mastocytosis (C96.2-)

What ICD-9 codes does Q82.2 map to? +

Per CMS GEMs, Q82.2 maps to ICD-9 codes: 75733. Useful for legacy data review and historical claim analysis.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on May 31, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Faster Approvals

Ready to Cut Your Enrollment Timeline in Half?

Join providers in all 50 states who handed off credentialing to a dedicated specialist. Create your free account in minutes and start enrolling the same day.

All 50 States Covered
No Long-Term Contracts
HIPAA HIPAA Compliant Platform
Dedicated Specialist Included